Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective

Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective

Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of young pharmacists 2022-07, Vol.14 (3), p.266-267
Hauptverfasser: Thangaraju, Pugazhenthan, TY, Sree Sudha, Venkatesan, Sajitha
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 267
container_issue 3
container_start_page 266
container_title Journal of young pharmacists
container_volume 14
creator Thangaraju, Pugazhenthan
TY, Sree Sudha
Venkatesan, Sajitha
description Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of those found in children under the age of 15.1-3 Globally in 2020, 1, 28,405 new leprosy patients were diagnosed. New paediatric cases were 8661 diagnosed with leprosy and 7216 patients with grade 2 disability by WHO region. Read more. . .
doi_str_mv 10.5530/jyp.2022.14.53
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3108086340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3108086340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c192t-fda39bd733262701bd5609f43537c250779e9b0086da65d97ee9a9f19914e4263</originalsourceid><addsrcrecordid>eNo1UE1Lw0AQXUTBUnv1vOA5cfYr2z2WWj-gqIjicdkms7XFZuNuIuTfm1idyzxm3rx5PEIuGeRKCbje903OgfOcyVyJEzIBo1XGFKjTfyzn4pzMUtrDWBq0MBPy_oJNF5uQdvWWBk9vYrdN1IdIH0OdRUxNqKtxt4p9-4EHN8yrkLoDXWMTf8HSJUw0owv6jDE1WLa7b7wgZ959Jpz99Sl5u129Lu-z9dPdw3KxzkpmeJv5ygmzqbQQvOAa2KZSBRgvhRK65Aq0Nmg2APOicoWqjEY0znhmDJMoeSGm5OqoO5j56jC1dh-6WA8vrWAwHw6FhIGVH1nlYDlF9LaJu4OLvWVgx_zskJ8d87NMWiXEDwtnYjk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3108086340</pqid></control><display><type>article</type><title>Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Thangaraju, Pugazhenthan ; TY, Sree Sudha ; Venkatesan, Sajitha</creator><creatorcontrib>Thangaraju, Pugazhenthan ; TY, Sree Sudha ; Venkatesan, Sajitha</creatorcontrib><description>Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of those found in children under the age of 15.1-3 Globally in 2020, 1, 28,405 new leprosy patients were diagnosed. New paediatric cases were 8661 diagnosed with leprosy and 7216 patients with grade 2 disability by WHO region. Read more. . .</description><identifier>ISSN: 0975-1483</identifier><identifier>EISSN: 0975-1505</identifier><identifier>DOI: 10.5530/jyp.2022.14.53</identifier><language>eng</language><publisher>Bangalore: InPharm</publisher><ispartof>Journal of young pharmacists, 2022-07, Vol.14 (3), p.266-267</ispartof><rights>2022. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Thangaraju, Pugazhenthan</creatorcontrib><creatorcontrib>TY, Sree Sudha</creatorcontrib><creatorcontrib>Venkatesan, Sajitha</creatorcontrib><title>Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective</title><title>Journal of young pharmacists</title><description>Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of those found in children under the age of 15.1-3 Globally in 2020, 1, 28,405 new leprosy patients were diagnosed. New paediatric cases were 8661 diagnosed with leprosy and 7216 patients with grade 2 disability by WHO region. Read more. . .</description><issn>0975-1483</issn><issn>0975-1505</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo1UE1Lw0AQXUTBUnv1vOA5cfYr2z2WWj-gqIjicdkms7XFZuNuIuTfm1idyzxm3rx5PEIuGeRKCbje903OgfOcyVyJEzIBo1XGFKjTfyzn4pzMUtrDWBq0MBPy_oJNF5uQdvWWBk9vYrdN1IdIH0OdRUxNqKtxt4p9-4EHN8yrkLoDXWMTf8HSJUw0owv6jDE1WLa7b7wgZ959Jpz99Sl5u129Lu-z9dPdw3KxzkpmeJv5ygmzqbQQvOAa2KZSBRgvhRK65Aq0Nmg2APOicoWqjEY0znhmDJMoeSGm5OqoO5j56jC1dh-6WA8vrWAwHw6FhIGVH1nlYDlF9LaJu4OLvWVgx_zskJ8d87NMWiXEDwtnYjk</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Thangaraju, Pugazhenthan</creator><creator>TY, Sree Sudha</creator><creator>Venkatesan, Sajitha</creator><general>InPharm</general><scope>AAYXX</scope><scope>CITATION</scope><scope>NAPCQ</scope></search><sort><creationdate>20220701</creationdate><title>Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective</title><author>Thangaraju, Pugazhenthan ; TY, Sree Sudha ; Venkatesan, Sajitha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c192t-fda39bd733262701bd5609f43537c250779e9b0086da65d97ee9a9f19914e4263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thangaraju, Pugazhenthan</creatorcontrib><creatorcontrib>TY, Sree Sudha</creatorcontrib><creatorcontrib>Venkatesan, Sajitha</creatorcontrib><collection>CrossRef</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of young pharmacists</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thangaraju, Pugazhenthan</au><au>TY, Sree Sudha</au><au>Venkatesan, Sajitha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective</atitle><jtitle>Journal of young pharmacists</jtitle><date>2022-07-01</date><risdate>2022</risdate><volume>14</volume><issue>3</issue><spage>266</spage><epage>267</epage><pages>266-267</pages><issn>0975-1483</issn><eissn>0975-1505</eissn><abstract>Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of those found in children under the age of 15.1-3 Globally in 2020, 1, 28,405 new leprosy patients were diagnosed. New paediatric cases were 8661 diagnosed with leprosy and 7216 patients with grade 2 disability by WHO region. Read more. . .</abstract><cop>Bangalore</cop><pub>InPharm</pub><doi>10.5530/jyp.2022.14.53</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0975-1483
ispartof Journal of young pharmacists, 2022-07, Vol.14 (3), p.266-267
issn 0975-1483
0975-1505
language eng
recordid cdi_proquest_journals_3108086340
source EZB-FREE-00999 freely available EZB journals
title Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T08%3A30%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Repurposing%20of%20Drugs%20for%20Non-responding%20Erythema%20Nodosum%20Leprosum%20Cases%20-%20A%20Perspective&rft.jtitle=Journal%20of%20young%20pharmacists&rft.au=Thangaraju,%20Pugazhenthan&rft.date=2022-07-01&rft.volume=14&rft.issue=3&rft.spage=266&rft.epage=267&rft.pages=266-267&rft.issn=0975-1483&rft.eissn=0975-1505&rft_id=info:doi/10.5530/jyp.2022.14.53&rft_dat=%3Cproquest_cross%3E3108086340%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3108086340&rft_id=info:pmid/&rfr_iscdi=true